TrialReader


Evaluation of the Benefits of Glucose Drinks During Childbirth

NCT01022697 — Not applicable, Completed, 4142 participants, University Hospital, Caen

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Randomized Control Study : Evaluation of the Benefits of Glucose Drinks During Childbirth

RegistryNCT01022697, acronym SOLISO
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, other
Enrollment4142 (Actual)
SponsorUniversity Hospital, Caen (Other)
ConditionsChildbirth
InterventionsGlucose drink (Other)
Datesstart 2008-01-01, primary completion 2012-07-01, completion 2012-07-01, first posted 2009-12-01, last updated 2026-04-02
Locations9 sites in France

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Childbirth All trials of Glucose drink

-Summary

Fear of full stomach when emergency general anaesthesia is required is the origin of fastening when giving birth. This behaviour does not warranty perfect security for the general anaesthesia. In addition, well being for women and new born is affected. Giving birth is finally compared to a sportive competition with high-energy needs. As Intravenous energy intake is not regulated by physiologic digestion, it can induce metabolic disorders for the mother that can be amplified for the foetus.

Oral glucose drinks could offer some benefits:

* gastric acidity would be decreased without significant increase in volumes.
* energy intake would further more active and more efficiency labour
* an increase in foetus well being

However, it has never been shown yet that such behaviour could offer those benefits. Also, it seems that there is not more vomiting, but most of the studies compared oral glucose intake to waterborne intake with the same volumes The expected efficacy is a reduction in labour duration and a reduction in percentage of extraction. Previous studies said that the lack of statistical power due to small number of subjects caused the absence of statistical significant relationship.

In addition, even though newborn have less acidosis, there is no clinical relationship proven.

The investigators propose a randomised multicentre study to assess efficacy of oral glucose drinks in comparison to traditional fastening when giving birth.

Main objective is to significantly reduce instrumental extraction rates. 5400 women will be included in the study in 2 years.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
AActive comparatorOther: Glucose drinkGlucose drink
BNo interventionFasting
  • Glucose drink (Other): 200 mL each 3 hours up to 8 cm of dilatation

+Outcome measures

Primary outcomes

  • Instrumental extraction rates [During childbirth]

+Eligibility

Sex: Female, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Age >= 18 yrs
* Entering for childbirth
* Informed written consent

Exclusion Criteria:

* more of 8 cm of dilatation
* Caesarean section planned
* natural delivery non-indicated
* pre-partum hemostasis troubles
* salicylic acid or anticoagulant treatment
* pre-eclampsia or HELLP syndrome
* diabetic neuropsy with troubles in gastric emptying
* IMC > 40 at the end of pregnancy
* understanding of the information
* under guardianship

+Locations (9)

FacilityCityCountryStatus
Hospital, AvranchesAvranchesFrance
Centre HospitalierBayeuxFrance
Clinique du ParcCaenFrance
University Hospital, CaenCaenFrance
Centre Hospitalier du RouvrayElbeufFrance
University Hospital, LilleLilleFrance
Hospital, Mont Saint AignanMont-Saint-AignanFrance
University Hospital, RouenRouenFrance
Centre Hospitalier Mémorial France Etats-UnisSaint-LôFrance

+Publications

  • Results publication: Simonet T, Gakuba C, Desmeulles I, Corouge J, Beucher G, Morello R, Gerard JL, Ducloy-Bouthors AS, Dreyfus M, Hanouz JL. Effect of Oral Carbohydrate Intake During Labor on the Rate of Instrumental Vaginal Delivery: A Multicenter, Randomized Controlled Trial. Anesth Analg. 2020 Jun;130(6):1670-1677. doi: 10.1213/ANE.0000000000004515. PMID 31702699

+Investigators

  • Thérèse SIMONET, MD, Principal investigator, University Hospital, Caen

My Notes